In line with this observation, in vivo treatment of NSCLC-derived cell lines with a low IFN-γ dose resulted in higher frequency of CD133+ cells compared with those treated with a high IFN-γ dose, indicating an enrichment in the CSC compartment due to low IFN-γ stimulation. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.